CN113181336A - 一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 - Google Patents
一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN113181336A CN113181336A CN202110653040.6A CN202110653040A CN113181336A CN 113181336 A CN113181336 A CN 113181336A CN 202110653040 A CN202110653040 A CN 202110653040A CN 113181336 A CN113181336 A CN 113181336A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- preparation
- gynecological diseases
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 87
- 201000010099 disease Diseases 0.000 title claims abstract description 61
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 61
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 241001646826 Isodon rubescens Species 0.000 claims abstract description 21
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 21
- 235000008397 ginger Nutrition 0.000 claims abstract description 21
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 20
- 235000011517 Terminalia chebula Nutrition 0.000 claims abstract description 20
- 206010046914 Vaginal infection Diseases 0.000 claims abstract description 20
- 201000008100 Vaginitis Diseases 0.000 claims abstract description 20
- 241001071917 Lithospermum Species 0.000 claims abstract description 19
- 244000277583 Terminalia catappa Species 0.000 claims abstract description 19
- 241000205578 Thalictrum Species 0.000 claims abstract description 18
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 17
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 17
- 244000018633 Prunus armeniaca Species 0.000 claims abstract description 16
- 235000009827 Prunus armeniaca Nutrition 0.000 claims abstract description 16
- 241000202726 Bupleurum Species 0.000 claims abstract description 10
- 241001494479 Pecora Species 0.000 claims abstract description 9
- 208000002003 vulvitis Diseases 0.000 claims abstract description 9
- 241000727913 Parthenocissus tricuspidata Species 0.000 claims abstract description 8
- 208000006374 Uterine Cervicitis Diseases 0.000 claims abstract description 8
- 206010008323 cervicitis Diseases 0.000 claims abstract description 8
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 7
- 239000000499 gel Substances 0.000 claims description 51
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 27
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 17
- 235000013399 edible fruits Nutrition 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 244000111489 Gardenia augusta Species 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 230000000857 drug effect Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 230000003628 erosive effect Effects 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 6
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 6
- 229960000520 diphenhydramine Drugs 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 241000212948 Cnidium Species 0.000 claims description 5
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 claims description 5
- 241000972673 Phellodendron amurense Species 0.000 claims description 5
- 241000219784 Sophora Species 0.000 claims description 5
- 229960002152 chlorhexidine acetate Drugs 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 claims description 4
- 241000146384 Glaux Species 0.000 claims description 4
- 241000207929 Scutellaria Species 0.000 claims description 4
- 241001671204 Stemona Species 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 241001596270 Aizoon Species 0.000 claims description 3
- 240000003152 Rhus chinensis Species 0.000 claims description 3
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 3
- 244000007853 Sarothamnus scoparius Species 0.000 claims description 3
- 229940049638 carbomer homopolymer type c Drugs 0.000 claims description 3
- 229940043234 carbomer-940 Drugs 0.000 claims description 3
- 239000011159 matrix material Substances 0.000 claims description 3
- 241000202722 Bupleurum falcatum Species 0.000 claims 2
- 244000301850 Cupressus sempervirens Species 0.000 claims 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 2
- 235000008434 ginseng Nutrition 0.000 claims 2
- 241000283707 Capra Species 0.000 claims 1
- 241001119335 Thalictrum ramosum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 48
- 230000008439 repair process Effects 0.000 abstract description 4
- 240000001972 Gardenia jasminoides Species 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 37
- 241000700159 Rattus Species 0.000 description 29
- 238000012795 verification Methods 0.000 description 20
- 208000003251 Pruritus Diseases 0.000 description 17
- 210000001215 vagina Anatomy 0.000 description 17
- 239000000243 solution Substances 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 241000234314 Zingiber Species 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000008961 swelling Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 206010061218 Inflammation Diseases 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000003385 bacteriostatic effect Effects 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 241000222122 Candida albicans Species 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000218691 Cupressaceae Species 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- 201000007100 Pharyngitis Diseases 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 229940095731 candida albicans Drugs 0.000 description 6
- 210000003756 cervix mucus Anatomy 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010068319 Oropharyngeal pain Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 238000001647 drug administration Methods 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 201000009240 nasopharyngitis Diseases 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 244000144725 Amygdalus communis Species 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 235000003893 Prunus dulcis var amara Nutrition 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 229940126680 traditional chinese medicines Drugs 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 229940059082 douche Drugs 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 2
- 241000510654 Bupleurum chinense Species 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034656 Contusions Diseases 0.000 description 2
- 206010011409 Cross infection Diseases 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010029803 Nosocomial infection Diseases 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 241000224526 Trichomonas Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010051873 Vaginal relaxation Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229940116229 borneol Drugs 0.000 description 2
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000009519 contusion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 229950002007 estradiol benzoate Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 238000012009 microbiological test Methods 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000008354 sodium chloride injection Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 244000236521 Bupleurum rotundifolium Species 0.000 description 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 244000067602 Chamaesyce hirta Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000207202 Gardnerella Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241000468460 Thalictrum aquilegiifolium Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010062558 Vaginal erosion Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010069055 Vulvovaginal pain Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- WDRFFJWBUDTUCA-UHFFFAOYSA-N chlorhexidine acetate Chemical compound CC(O)=O.CC(O)=O.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WDRFFJWBUDTUCA-UHFFFAOYSA-N 0.000 description 1
- 229960001884 chlorhexidine diacetate Drugs 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 210000001752 female genitalia Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- -1 liquid paraffin Chemical compound 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/904—Stemonaceae (Stemona family), e.g. croomia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了治疗妇科疾病的中药组合物,按重量份数计包括金柴胡1~40份、羊膻七1~40份、蛇床子1~40份、苦参1~40份、柴胡1~40份、苦杏仁1~40份、大对经草1~40份、黄柏1~40份、生姜1~40份、紫草1~40份、百部1~40份、诃子1~40份、黄芩1~40份、冬凌草1~40份、唐松草1~40份、五倍子1~40份、栀子1~40份、地肤子1~40份,其可在有效缓解并治疗外阴炎、阴道炎、宫颈炎等妇科疾病,达到良好的治疗、修复及的防护效果;本发明还提供了由该中药组合物制备得到的制剂及制备方法;及该中药组合物在制备治疗外阴炎、阴道炎、宫颈炎的药物中的应用。
Description
技术领域
本发明涉及中医药技术领域,具体而言,涉及一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用。
背景技术
妇科炎症是女性的常见疾病,主要是指女性生殖器官如外阴、阴道等受到各种致病菌感染后发生炎症,具体包括女性外阴炎、阴道炎、宫颈糜烂、宫颈炎、盆腔炎等,是妇科常见病和多发病。炎症常表现为外阴及阴道瘙痒,有的局部发生糜烂,伴灼痛、尿痛、尿频、阴道分泌物增多、红肿等。已婚妇女中比较常见,该病不容易根除,如果久治不愈,比如宫颈糜烂就有可能发展为宫颈癌。妇科疾病已经成为隐藏在女性体内的一号杀手,也是世界上最隐晦的疾病,大多是因不注意经期和产后卫生或性生活不洁造成的。
目前治疗该病的方法有物理疗法和药物疗法,物理疗法不容易操作且损伤比较大。药物疗法包括西药、中药以及中西药结合,目前西药治疗妇科炎症,所用药物主要是利用抗生素类和激素类,长期使用会对肝肾等器官造成一定的损害,而且容易使病菌产生耐药性,破坏阴道造成菌群间的相互制约关系而导致菌群失调,破坏阴道自洁和防御能力,导致病情反复,不能彻底根除,停药后容易复发。中药以口服为主,见效慢,疗效不尽人意。
发明内容
本发明的第一个目的在于提供一种治疗妇科疾病的中药组合物,其可在有效缓解并治疗外阴炎、阴道炎、宫颈炎等妇科疾病,达到良好的治疗、修复及的防护效果。
本发明的第二个目的在于提供一种治疗妇科疾病的中药制剂及其制备和应用,其可促进药物的高效吸收和充分发挥药效,提高治疗妇科疾病的疗效。
本发明的实施例通过以下技术方案实现:
一种治疗妇科疾病的中药组合物,按重量份数计,包括金柴胡1~40份、羊膻七1~40份、蛇床子1~40份、苦参1~40份、柴胡1~40份、苦杏仁1~40份、大对经草1~40份、黄柏1~40份、生姜1~40份、紫草1~40份、百部1~40份、诃子1~40份、黄芩1~40份、冬凌草1~40份、唐松草1~40份、五倍子1~40份、栀子1~40份、地肤子1~40份。
上述中药组合物在制备治疗外阴炎、阴道炎、宫颈炎、宫颈糜烂、盆腔炎的药物中的应用。
一种治疗妇科疾病的中药制剂,包括上述中药组合物和药学上可接受的辅料。
一种治疗妇科疾病的中药制剂的制备方法,包括如下步骤:
S1:按照比例称取各原料,将原料干燥、粉碎成细粉,过筛,并灭菌;
S2:将上述原料细粉加入到水中,煎煮4h后,滤去沉淀,取煎液,将上清液过滤、浓缩至清膏;
S3:将丙二醇、薄荷脑、冰片、甘油、维他命E1、醋酸氯己定和苯海拉明混合搅拌均匀,加入清膏中,混合搅拌均匀,获得药效溶液;
S4:将得到的药效溶液配合不同的辅料,即可制成不同剂型的制剂。
本发明实施例的技术方案至少具有如下优点和有益效果:
1.本发明中药组合物中各组分协同增效,可在快速发挥治疗作用,且中药组合物均通过天然野生药材配伍而成,优选将组合物制成阴道给药制剂,不经口服,可减少不良反应的发生,同时功效全面,疗效卓越,可直接接触病灶,药物吸收迅速,靶向性的开展深层治疗,操作简便,临床使用安全性好,治愈率达90%以上。
2.本发明中药组合物可修复阴道内酸性环境,保护正常菌群的生长,促进益生菌的生长,调节菌群平衡;同时可以有效的清除自由基和稳定细胞膜,形成防护膜,有效隔离外界细菌、真菌和滴虫等微生物侵入,防止交叉及二次感染,起到辅助治疗的作用,达到良好的修复及防护效果。
3.本发明中药组合物可激活凝血系统,防止出血并加速伤口愈合,促进上皮细胞修复再生,减少疤痕,保持阴道内贴膜光滑有弹性;并通过抗组胺作用、局部清凉作用以及神经末梢麻醉作用等机制起到止痒作用,从而进一步提升组方的疗效,达到良好的治疗效果。
4.本发明准备方法将各组分处理成超微粉,再进行多级提取,其可最大程度的发挥各组分的药效,从而所得的药剂活性成分更高,促进药物的高效吸收和充分发挥药效,提高治疗妇科疾病的疗效。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面将对本发明实施例中的技术方案进行清楚、完整地描述。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
下面对本发明实施例提供的一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用进行具体说明。
一种治疗妇科疾病的中药组合物,按重量份数计,包括金柴胡1~40份、羊膻七1~40份、蛇床子1~40份、苦参1~40份、柴胡1~40份、苦杏仁1~40份、大对经草1~40份、黄柏1~40份、生姜1~40份、紫草1~40份、百部1~40份、诃子1~40份、黄芩1~40份、冬凌草1~40份、唐松草1~40份、五倍子1~40份、栀子1~40份、地肤子1~40份。
进一步地,按重量份数计,包括金柴胡10~40份、羊膻七10~40份、蛇床子10~40份、苦参10~40份、柴胡10~40份、苦杏仁10~40份、大对经草10~40份、黄柏10~40份、生姜10~40份、紫草15~40份、百部15~40份、诃子15~40份、黄芩15~40份、冬凌草15~40份、唐松草15~40份、五倍子15~40份、栀子15~40份、地肤子15~40份。
进一步地,按重量份数计,包括金柴胡35份、羊膻七20份、蛇床子40份、苦参10份、苦杏仁40份、大对经草20份、黄柏20份、生姜40份、紫草40份、柴胡40份、百部10份、诃子10份、黄芩15份、冬凌草30份、唐松草30份、五倍子30份、栀子30份、地肤子10份。
进一步地,按重量分数计,包括金柴胡30份、羊膻七20份、蛇床子30份、苦参20份、苦杏仁30份、大对经草30份、黄柏30份、生姜20份、紫草30份、柴胡20份、百部20份、诃子20份、黄芩20份、冬凌草20份、唐松草10份、五倍子10份、栀子15份、地肤子15份。
进一步地,按重量分数计,包括金柴胡40份、羊膻七10份、蛇床子20份、苦参25份、苦杏仁20份、大对经草20份、黄柏40份、生姜30份、紫草15份、柴胡10份、百部10份、诃子30份、黄芩20份、冬凌草30份、唐松草20份、五倍子10份、栀子20份、地肤子20份。
本发明所述的中药组合物中,依据《陕西省药材标准(2015年版)》、《中国药典(2020年版)》、《中国药典(2015年版)》、《陕西中草药》记载,各组分功能与主治如下:
金柴胡:味辛、苦,凉。功效为清热疏风,化痰平喘,解毒消肿。主治感冒发热,咽喉肿痛,支气管炎,喘咳,肺炎,痈肿疔毒,乳腺炎,毒蛇咬伤,肾炎,膀胱炎等炎症疾病。
羊膻七:味辛、微苦,性温。功效为散寒,利湿,化积,解毒,消肿。祛风活血,解毒消肿。主治皮肤瘙痒、风寒感冒,咽喉肿痛,疟疾等;外用皮肤搔痒。
蛇床子:味辛、苦,性温。功效为燥湿祛风,杀虫止痒,温肾壮阳。主治阴痒带下,湿疹瘙痒,湿痹腰痛,肾虚阳痿,宫冷不孕。
苦参:味苦,性寒。功效为清热燥湿,杀虫,利尿。主治热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风,外治滴虫性阴道炎。
苦杏仁:味苦,性温。降气止咳平喘,润肠通便。
大对经草:味苦微辛,性平。功效为活血调经,止血止痛,利水消肿,除风湿。主治月经不调,跌打损伤,骨折,出血等。
黄柏:味苦,性寒。功效为清热燥湿,泻火除蒸,解毒疗疮。主治湿热泻痢,黄疸尿赤,带下阴痒,热淋涩痛,脚气痿蹙,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹湿疮。
生姜:味辛,性微温。功效为解表散寒,温中止呕,温肺止咳,解毒。主治风寒感冒,脾胃寒症,胃寒呕吐,肺寒咳嗽,解鱼蟹毒。
紫草:味甘、咸,寒。功效为凉血,活血,解毒透疹。主治血热毒盛,斑疹紫黑,麻疹不透,疮疡,湿疹,水火烫伤,温热斑疹,湿热黄疸,紫癜,吐、衄、尿血,淋浊,热结便秘,烧伤,湿疹,丹毒,痈疡。
柴胡:味辛、苦,性微寒。功效为和解表里,疏肝解郁,升阳举陷,退热截疟。主治感冒发热,寒热往来,胸胁胀痛,月经不调,子宫脱垂,脱肛。
百部:味甘、苦,性微温。功效为润肺下气止咳,杀虫灭虱。主治新久咳嗽,肺痨咳嗽,顿咳;外用于头虱,体虱,蛲虫病,阴痒。
诃子:味苦、酸、涩,性平。功效为涩肠止泻,敛肺止咳,降火利咽。主治久泻久痢,便血脱肛,肺虚喘咳,久嗽不止,咽痛音哑。
黄芩:味苦,性寒。功效为清热燥湿,泻火解毒,止血,安胎。主治湿温、暑湿,胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。
冬凌草:味苦、甘,性微寒。功效为清热解毒,活血止痛。主治咽喉肿痛,瘕瘕痞块,蛇虫咬伤。
唐松草:味苦,性寒。功效为清热泻火,燥湿解毒。主治热病心烦,湿热泻痢,肺热咳嗽,目赤肿痛,痈肿疮疖。
五倍子:味酸、涩,性寒。功效为敛肺降火,涩肠止泻,敛汗,止血,收湿敛疮。主治肺虚久咳,肺热痰嗽,久泻久痢,自汗盗汗,消渴,便血痔血,外伤出血,痈肿疮毒,皮肤湿烂。
栀子:味苦,性寒。功效为泻火除烦,清热利湿,凉血解毒;外用消肿止痛。主治热病心烦,湿热黄疸,淋证涩痛,血热吐衄,目赤肿痛,火毒疮疡,外治扭挫伤痛。
地肤子:味辛、苦,性寒。功效为清热利湿,祛风止痒。主治小便涩痛,阴痒带下,风疹,湿疹,皮肤瘙痒。
维他命E1:一种脂溶性维生素,又称生育酚,是最主要的抗氧化剂之一。溶于脂肪和乙醇等有机溶剂中。功效为改善脂质代谢,稳定细胞膜和细胞内脂类部分,促进毛细血管及小血管的增生,改善周围循环。在烧伤、冻伤、毛细血管出血、更年期综合症、美容等方面有很好的疗效。
薄荷脑:味辛,性凉。功效为疏风,清热。主治风热感冒,头痛,目赤,咽喉肿痛,齿痛,皮肤瘙痒。
冰片:味辛、苦,微寒。功效为开窍醒神,清热散毒,明目退翳。主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。
醋酸氯己定:为阳离子型表面活性防腐剂,具有抗菌谱广,抗菌作用较强的特点。其作用机制是改变细菌细胞膜的通透性。但对芽胞、病毒及耐酸菌无效。
苯海拉明:乙二胺类抗组胺药。能对抗或减弱组胺对血管、胃肠和支气管平滑肌的作用。适用于皮肤黏膜的过敏性疾病,乳膏外用治虫咬、神经性皮炎、瘙痒症等。
本发明上述药物组分间协同作用,从多方面发挥治疗作用:
栀子、五倍子、唐松草、冬凌草、紫草、醋酸氯己定针对细菌和真菌具有多重抑制作用;蛇床子、苦参、百部、诃子、苦杏仁能够协同杀滴虫等微生物的作用,从而起到的主要治疗作用,同时通过多种中药的协同进行功效叠加,并防止耐药;而生姜、黄柏、维生素E1可以有效的清除自由基和稳定细胞膜,形成防护膜,有效隔离外界细菌、真菌和滴虫等微生物侵入,防止交叉及二次感染,起到辅助治疗的作用;同时,蛇床子、黄柏、黄芩、生姜、栀子、维他命E也能修复阴道的酸性环境,保护正常菌群的生长,促进益生菌的生长,调节菌群平衡,进一步促进疾病治疗。此外,金柴胡、黄芩、柴胡、大对经草也能促进阴道糜烂口血小板的聚集,激活凝血系统,可防止出血并加速伤口愈合,启动并促进上皮细胞修复再生,减少疤痕,保持阴道内贴膜光滑有弹性。最后,羊膻七、地肤子、薄荷脑、冰片和苯海拉明则通过抗组胺作用、局部清凉作用以及神经末梢麻醉作用等机制起到止痒作用,从而进一步提升组方的疗效。上述药材均以天然野生药材配伍而成,优选将组合物与适宜的辅料制成阴道给药制剂,不经口服,可减少不良反应的发生,同时功效全面,疗效卓越,可直接接触病灶,药物吸收迅速,靶向性的开展深层治疗,操作简便,临床使用安全性好,治愈率达90%以上。
上述中药组合物在制备治疗外阴炎、阴道炎、宫颈炎、宫颈糜烂、盆腔炎的药物中的应用。
一种治疗妇科疾病的中药制剂,包括上述中药组合物和药学上可接受的辅料。
上述中药制剂的剂型包括凝胶、喷剂、洗液、乳膏或乳霜。
一种治疗妇科疾病的中药制剂的制备方法,包括如下步骤:
S1:按照比例称取各原料,将原料干燥、粉碎成10目、50目、200目、300目、400目、500目等不同细度的粉末细粉,过筛,并使用紫外灯对其进行灭菌;
S2:将上述原料细粉加入到水中,煎煮4h后,滤去沉淀,取煎液,将上清液过滤、浓缩至清膏或浸膏、流浸膏;
S3:将丙二醇、薄荷脑、冰片、甘油、维他命E1、醋酸氯己定和苯海拉明混合搅拌均匀,加入上述清膏或浸膏、流浸膏中,混合搅拌均匀,获得药效溶液;
S4:将得到的药效溶液配合不同的辅料,即可制成不同剂型的制剂。
当制备成凝胶制剂时:S4中将药效溶液中加入基于卡波姆940的凝胶基质,混合搅拌均匀,将凝胶灌装至给药器内,密封,即得凝胶制剂。
当制备成喷剂时,所述辅料包括脂肪酸异丙酯类溶剂、脂肪油、乙醇、液体石蜡、乙酸乙酯、乙烯类合成高分子多聚物、纤维素衍生物中的一种或几种。
当制备成洗液时,所述辅料包括乙醇、甘油、阿拉伯胶、甲基纤维素、硅酸铝、丙二醇、肉豆蔻酸异丙酯、纯化水、去离子水中的一种或几种。
当制备成乳膏或乳霜时,所述辅料包括油相成分和水相成分;所述油相成分包括硬脂酸、石蜡、单硬脂酸甘油酯、高级醇、二甲硅油、司盘、液状石蜡、凡士林、植物油、动物油脂以及新型复合型乳化剂中的一种或几种;所述水相成分包括甘油、丙二醇、十二烷基硫酸钠、纯化水、去离子水中的一种或几种。
实施例1
一种治疗妇科疾病的中药组合物,包括:金柴胡30g、羊膻七20g、蛇床子30g、苦参20g、苦杏仁30g、大对经草30g、黄柏30g、生姜20g、紫草30g、柴胡20g、百部20g、诃子20g、黄芩20g、冬凌草20g、唐松草10g、五倍子10g、栀子15g、地肤子15g。
一种治疗妇科疾病的凝胶制剂的制备方法,该方法的制备步骤如下:1)按照比例称取金柴胡、羊膻七、蛇床子、苦参、苦杏仁、大对经草、黄柏、生姜、紫草、柴胡、百部、诃子、黄芩、冬凌草、唐松草、五倍子、栀子、地肤子,并以此为原材料;2)将原材料干燥、粉碎成细粉,过筛,并使用紫外灯对其进行灭菌;3)原材料细粉加入到水中,加水煎煮4h后,取煎液,滤去沉淀,将上清液过滤、浓缩,至清膏;4)将丙二醇、薄荷脑、冰片、甘油、维他命E1、醋酸氯己定和苯海拉明混合搅拌均匀,加入清膏中,混合搅拌均匀,获得药效溶液;5)将药效溶液加入基于卡波姆940的凝胶基质,混合搅拌均匀,将凝胶灌装至给药器内,密封,即得所述的消炎杀菌的妇科凝胶制剂。
实施例2
一种治疗妇科疾病的中药组合物,包括:金柴胡40g、羊膻七10g、蛇床子20g、苦参25g、苦杏仁20g、大对经草20g、黄柏40g、生姜30g、紫草15g、柴胡10g、百部10g、诃子30g、黄芩20g、冬凌草30g、唐松草20g、五倍子10g、栀子20g、地肤子20g。
一种治疗妇科疾病的凝胶制剂的制备方法,与实施例1一致。
实施例3
一种治疗妇科疾病的中药组合物,包括:金柴胡35g、羊膻七20g、蛇床子40g、苦参10g、苦杏仁40g、大对经草20g、黄柏20g、生姜40g、紫草40g、柴胡40g、百部10g、诃子10g、黄芩15g、冬凌草30g、唐松草30g、五倍子30g、维他命E1 40g、栀子30g、地肤子10g。
一种治疗妇科疾病的凝胶制剂的制备方法,与实施例1一致。
实施例4
一种治疗妇科疾病的中药组合物,包括:金柴胡1g、羊膻七40g、蛇床子1g、苦参1g、苦杏仁1g、大对经草40g、黄柏1g、生姜40g、紫草1g、柴胡1g、百部1g、诃子1g、黄芩40g、冬凌草1g、唐松草1g、五倍子40g、栀子1g、地肤子40g。
一种治疗妇科疾病的洗液的制备方法,与实施例1的区别在于:步骤5)中,将药效溶液与乙醇、甘油、阿拉伯胶、甲基纤维素、硅酸铝、丙二醇、肉豆蔻酸异丙酯、纯化水混合搅拌均匀,灌装、密封,即得洗液。
实施例5
一种治疗妇科疾病的中药组合物,包括:金柴胡40g、羊膻七40g、蛇床子1g、苦参1g、苦杏仁1g、大对经草40g、黄柏1g、生姜40g、紫草1g、柴胡1g、百部1g、诃子1g、黄芩40g、冬凌草1g、唐松草1g、五倍子40g、栀子1g、地肤子40g。
一种治疗妇科疾病的喷剂的制备方法,与实施例1的区别在于:步骤5)中,将药效溶液与乙醇、甘油、阿拉伯胶、甲基纤维素、硅酸铝、丙二醇、肉豆蔻酸异丙酯、纯化水混合搅拌均匀,灌装、密封,即得喷剂。
实施例6
一种治疗妇科疾病的中药组合物,包括:金柴胡20g、羊膻七30g、蛇床子20g、苦参25g、苦杏仁30g、大对经草30g、黄柏15g、生姜20g、紫草15g、柴胡15g、百部10g、诃子15g、黄芩20g、冬凌草15g、唐松草25g、五倍子20g、栀子10g、地肤子20g。
一种治疗妇科疾病的喷剂的制备方法,与实施例1的区别在于:步骤5)中,将药效溶液与硬脂酸、石蜡、单硬脂酸甘油酯、植物油、甘油、丙二醇、十二烷基硫酸钠、纯化水混合搅拌均匀,灌装、密封,即得乳膏剂。
实验例
1.微生物检验
将实施例1-3制得的凝胶制剂进行微生物检验,按《一次性使用卫生标准GB15979-2002》规定的方法进行检验,结果如表1所示:
表1:实施例1-3制得凝胶制剂微生物检验结果
实施例1 | 实施例2 | 实施例3 | |
细菌菌落总数(cfu/g) | <4cfu/g | <4cfu/g | <4cfu/g |
大肠杆菌 | 未检测 | 未检测 | 未检测 |
绿脓杆菌 | 未检测 | 未检测 | 未检测 |
金黄色葡萄球菌 | 未检测 | 未检测 | 未检测 |
溶血性链球菌 | 未检测 | 未检测 | 未检测 |
真菌菌落总数(cfu/g) | <4cfu/g | <4cfu/g | <4cfu/g |
由表1数据可知:实施例1-3制得的凝胶制剂微生物检验结果均符合要求。
2.安全性测试
将实施例1-3制得的凝胶进行安全性检验,按照国家食品药品监督管理局2003年9月1日施行的《药物非临床研究质量管理规范》的要求进行检测。具体为遵循国家食品药品监督管理局“化学药物刺激性、过敏性和溶血性研究技术指导原则”执行。实验结果显示,本发明实施例1-3制得的妇科凝胶在7天内均对皮肤无刺激性,表明本发明提供的凝胶有较高的安全性。
3.稳定性测试
将实施例1-3制得的凝胶分别置于-10±1℃和60±2℃的条件下,密封放置3个月,肉眼观察妇科凝胶的状态,测试结果如表2所示:
表2:实施例1-3制得的凝胶的稳定性测试结果
实施例1 | 实施例2 | 实施例3 | |
-10±1℃ | 无变化 | 无变化 | 极少量沉淀 |
60±2℃ | 无变化 | 无变化 | 无变化 |
由表2数据可知:本发明实施例1-3制得凝胶制剂稳定性较好。
4.抑菌率检测
按照GB15979-2002《一次性使用卫生用品卫生标准》附录C4以及《消毒技术规范》2002版中的试验条件,测试实施例1-3制备的凝胶剂对金黄色葡萄球菌、大肠杆菌、白色念球菌作用5、8、15min时的抑菌率,试验重复三次,取平均值。结果如表3所示:
表3:实施例1-3制得的凝胶对不同菌种的平均抑菌率(%)
由表3数据可知:本发明的凝胶对阴道炎常规的感染菌,如金黄色葡萄球菌、大肠杆菌、白色念球菌的平均抑菌率达90%以上,
5.抑菌活性测定
在3个灭菌培养皿中分别加入上述金黄色葡萄球菌、大肠杆菌、白色念球菌的悬浮液100μL,再倒入40℃的灭菌培养基混合均匀。凝固后,用无菌镊子夹取含实施例1-3制备的凝胶剂的滤纸片,放置于距培养皿边缘15mm处,轻轻按压,使滤纸片紧贴培养基。每个重复进行3次。将培养皿倒置于30℃恒温培养箱中,分别培养24、48h,然后观察含药滤纸片周围有无抑菌圈,以十字交叉法测定其抑菌直径(包括纸片直径)。每个重复测量3次,取平均值。其中,抑菌圈即表示抗菌效果,即抑菌圈直径越大,抗菌效果越好。结果如表4所示:
表4:实施例1-3制得的凝胶对不同菌种的平均抑菌圈直径(mm)
组别 | 金黄色葡萄球菌 | 大肠杆菌 | 白色念球菌 |
实施例1 | 24.32 | 27.49 | 36.65 |
实施例2 | 26.85 | 27.72 | 38.60 |
实施例3 | 23.67 | 25.04 | 38.72 |
由表4数据可知:本发明实施例1-3制备的凝胶剂对不同菌种的平均抑菌圈直径较大,可有效抑制金黄色葡萄球菌、大肠杆菌、白色念球菌。
6.动物药效实验
6.1实验材料:1)受试药:按照实施例1-3方法制备得到的凝胶;2)实验动物:60只成年健康Wistar大鼠,体重250g;3)实验试剂:造模试剂:苯甲酸雌二醇注射液,注射用硫酸链霉素。
6.2造模:60只大鼠分别于给药前第1~3天每只皮下注射0.5mg的苯甲酸雌二醇注射液(每日上午进行)。
对其中50只大鼠阴道内注入注射用硫酸链霉素,每只每次50μg(上午进行);然后向阴道内注入混合菌(加德纳菌GV10-1菌,白色念珠菌,B族链球菌悬液)(1×108CFU/mL),每只每次50μL(下午进行),每天1次,连续3d,得到混合性阴道炎模型大鼠。
对另外10只大鼠按照混合性阴道炎模型造模过程一遍,不同的是:10只大鼠阴道内接种50μL不含混合菌株的半固体培养基,作为空白对照组大鼠。
最后,50只混合性阴道炎模型大鼠和10只空白对照组大鼠,分别于分组前向大鼠阴道内注入50μL无菌PBS,移液枪轻轻吹打5次后吸出冲洗液(约250μL),取50μL用于显微镜下观察是否存在阴道混合菌感染。
6.3分组及给药:
1)分组:选取感染成功的50只混合性阴道炎模型大鼠按体重和菌株负荷量随机平均分为模型组、阳性药组和药物验证组1、药物验证组2和药物验证组3;以及空白对照组;每组10只动物。
2)给药:其中模型组给药:0.9%氯化钠注射液;阳性药组给药:市售的好女人妇科抑菌凝胶;药物验证组1给药:实施例1制备得到的凝胶制剂;药物验证组2给药:实施例2制备得到的凝胶制剂;药物验证组3给药:实施例3制备得到的凝胶制剂。另外,空白对照组给予等量的0.9%氯化钠注射液。各组每天给药1次,连续给药5d。
6.4实验数据采集和结果判定:于末次给药后处死大鼠,观察大鼠阴道局部特征、随后取出、吸干表面液体后称量阴道重量,计算阴道指数(阴道指数=阴道重量/动物体重),同时测量阴道pH。另外收集分组前、治疗5d后的阴道灌洗液,按照梯度稀释后进行培养,计数100μL灌洗液中的菌落数。
6.4.1各组大鼠用药后的总疗效,其中治疗效果的判断标准包括:1)痊愈:症状完全缓解;2)好转:症状大部分缓解;3)无效:症状无明显变化;测试结果见表5:
表5:各组大鼠用药后的总疗效
组别 | 例数 | 痊愈 | 好转 | 无效 | 总有效率(%) |
空白对照组 | 10 | 10 | 0 | 0 | 100 |
模型组 | 10 | 0 | 0 | 10 | 0 |
阳性药组 | 10 | 4 | 3 | 3 | 40 |
药物验证组1 | 10 | 8 | 1 | 1 | 80 |
药物验证组2 | 10 | 9 | 1 | 0 | 90 |
药物验证组3 | 10 | 9 | 0 | 1 | 90 |
由表5数据可知:本发明实施例1-3方法制备得到的凝胶制剂用药后总疗效分别为80%、90%、90%。从痊愈和好转的数据来看,与阳性药组和模型组大鼠的总有效率相比,本发明实施例1-3方法制备得到的凝胶能够有效治疗缓解大鼠阴道炎。
6.4.2各组大鼠用药后的阴道局部特征;测试结果见表6:
表6:各组大鼠用药后阴道局部特征
组别 | 例数 | 水肿 | 血点、斑 | 充血 | 糜烂、溃疡 |
空白对照组 | 10 | 0 | 0 | 0 | 0 |
模型组 | 10 | 3 | 2 | 3 | 2 |
阳性药组 | 10 | 1 | 0 | 2 | 0 |
药物验证组1 | 10 | 2 | 0 | 1 | 0 |
药物验证组2 | 10 | 1 | 1 | 0 | 0 |
药物验证组3 | 10 | 1 | 0 | 1 | 0 |
由表6数据可知:本发明实施例1-3制得的凝胶制剂在大鼠用药后,从阴道局部特征观察来看:药物验证组1~药物验证组3与模型组相比,大鼠阴道局部特征明显得到改善,并且恢复至正常水平;药物验证组1~药物验证组3与阳性药组相比,阴道充血较少,其余效果基本一致,作为中药类药物的效果与西药效果基本一致甚至疗效更好,说明本发明中药组合物对阴道炎阴道局部特征有显著的疗效。
6.4.3各组大鼠用药后的阴道灌洗液混合菌数目;测试结果见表7:
表7:各组大鼠用药后阴道灌洗液混合菌数目
组别 | 例数 | 干预前(×10<sup>2</sup>CFU/100uL) | 干预后(×10<sup>2</sup>CFU/100uL) |
空白对照组 | 8 | 1.31±0.20 | 1.36±0.14 |
模型组 | 10 | 10.53±1.68 | 14.20±2.23 |
阳性药组 | 10 | 10.68±1.48 | 8.26±1.31 |
药物验证组1 | 9 | 10.48±1.56 | 7.8±1.33 |
药物验证组2 | 10 | 10.32±1.96 | 8.11±1.43 |
药物验证组3 | 9 | 10.53±1.41 | 7.68±0.91 |
由表7数据可知:与空白对照组比较,用药第5天后模型组阴道灌洗液混合菌计数显著增加(P<0.01);与模型组比较,用药第5天后药物验证组1~药物验证组3阴道灌洗液混合菌计数显著降低(P<0.01,P<0.01,P<0.01),说明本发明实施例1~实施例3制得的凝胶制剂抗菌效果越好,对阴道炎阴道局部特征有显著的疗效,能够有效治疗缓解大鼠阴道炎。
6.4.4在给药前对各组大鼠的阴道分泌物经0.1级pH试纸进行检测,结果如表8所示:
表8:各组大鼠用药后阴道灌洗液pH值
组别 | 例数 | 干预前 | 干预后 |
空白对照组 | 8 | 4.06±0.33 | 4.03±0.29 |
模型组 | 10 | 7.19±0.33 | 6.68±0.84 |
阳性药组 | 10 | 6.84±0.79 | 4.77±0.69 |
药物验证组1 | 9 | 7.53±0.47 | 4.63±0.49 |
药物验证组2 | 10 | 7.07±0.44 | 4.34±0.48 |
药物验证组3 | 9 | 7.38±0.52 | 4.48±0.72 |
由表8数据可知:正常组、模型组及药物验证组1-3制得的凝胶给药组阴道分泌物pH值分别为4.06±0.33、7.19±0.33、7.53±0.47、7.07±0.44、7.38±0.52;给药5天后,正常组、模型组及药物验证组1-3制得的凝胶给药组阴道分泌物pH值分别为4.03±0.29、6.68±0.84、4.63±0.49、4.34±0.48、3.98±0.72,提示模型组大鼠连续接种混合菌3d,致病菌经5d在大鼠阴道体内不断繁殖,优势菌逐渐减少,pH值明显增加(P<0.01);经阴道给予实施例1-3制得的凝胶治疗5d后,与同期模型组比较,pH值明显降低(P<0.01,P<0.01,P<0.01)。
7.功效和使用感测试
将实施例1-3制得的凝胶对80名患有不同程度阴道松弛及妇科炎症的女性患者给药。相应的实验方案为:1)将受试者随机分成4组,每组20人,记为实验组1-3及对照组,并分别使用实施例1-3制备的凝胶以及市售的好女人妇科抑菌凝胶。所有的药物均采用专用容器注入阴道内,保留20min以上,每晚一次,7天为一疗程。使用3个疗程后,统计效果;2)其中,功效判断标准:有效为症状明显好转;无效为症状无明显变化;3)使用感判断标准:“优”为使用过程中无任何不适;“差”为使用过程中出现灼烧感、粘腻感等不适。测试结果见表9:
表9:实施例1-3制得的凝胶功效和使用感测试结果
由表9数据可知:本发明实验组1-3的治疗有效率分别为95%、90%和95%,且使用感优异;对照组采用市售的西药好女人妇科抑菌凝胶的治疗有效率为85%,使用感较好;说明本发明实施例1-3制得的凝胶对阴道松弛及妇科炎症具有更好的疗效及使用感。
典型病例资料:
1.宋女士,年纪45岁已婚,由于工作环境的高污染情况,导致私处发生妇科疾病,症状为异味、虫性阴道炎等问题,症状时长2年,使用实施例1制备的凝胶1个疗程后好转,使用3个疗程治愈疾病并康复。
2.郑女士,年纪27岁已婚,由于夫妻生活卫生不洁,导致细菌会进入到阴道内而引起阴道炎,症状为淡白色的阴道分泌物并具有鱼腥味、阴道疼痛、瘙痒或灼痛感,症状时长3个月,使用实施例2制备的凝胶1个疗程后好转,使用2个疗程治愈疾病并康复。
3.王女士,年纪26岁未婚,由于使用的卫生纸存在安全隐患,患上外阴炎和阴道炎,症状为阴道分泌物异常、异味、瘙痒,症状时长1个月,使用实施例3制备的凝胶1个疗程后即治愈疾病。
综上所述,本发明实施例制备得到的凝胶能够有效治疗不同病因引起的外阴炎、阴道炎、宫颈炎、宫颈糜烂、盆腔炎等妇科疾病,并起到较好地根治效果。
本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应所述以权利要求的保护范围为准。
Claims (10)
1.一种治疗妇科疾病的中药组合物,其特征在于,按重量份数计,包括金柴胡1~40份、羊膻七1~40份、蛇床子1~40份、苦参1~40份、柴胡1~40份、苦杏仁1~40份、大对经草1~40份、黄柏1~40份、生姜1~40份、紫草1~40份、百部1~40份、诃子1~40份、黄芩1~40份、冬凌草1~40份、唐松草1~40份、五倍子1~40份、栀子1~40份、地肤子1~40份。
2.根据权利要求1所述的治疗妇科疾病的中药组合物,其特征在于,按重量份数计,包括金柴胡10~40份、羊膻七10~40份、蛇床子10~40份、苦参10~40份、柴胡10~40份、苦杏仁10~40份、大对经草10~40份、黄柏10~40份、生姜10~40份、紫草15~40份、百部15~40份、诃子15~40份、黄芩15~40份、冬凌草15~40份、唐松草15~40份、五倍子15~40份、栀子15~40份、地肤子15~40份。
3.根据权利要求1所述的治疗妇科疾病的中药组合物,其特征在于,按重量份数计,包括金柴胡35份、羊膻七20份、蛇床子40份、苦参10份、苦杏仁40份、大对经草20份、黄柏20份、生姜40份、紫草40份、柴胡40份、百部10份、诃子10份、黄芩15份、冬凌草30份、唐松草30份、五倍子30份、栀子30份、地肤子10份。
4.根据权利要求1所述的治疗妇科疾病的中药组合物,其特征在于,按重量份数计,包括金柴胡30份、羊膻七20份、蛇床子30份、苦参20份、苦杏仁30份、大对经草30份、黄柏30份、生姜20份、紫草30份、柴胡20份、百部20份、诃子20份、黄芩20份、冬凌草20份、唐松草10份、五倍子10份、栀子15份、地肤子15份。
5.根据权利要求1所述的治疗妇科疾病的中药组合物,其特征在于,按重量份数计,包括金柴胡40份、羊膻七10份、蛇床子20份、苦参25份、苦杏仁20份、大对经草20份、黄柏40份、生姜30份、紫草15份、柴胡10份、百部10份、诃子30份、黄芩20份、冬凌草30份、唐松草20份、五倍子10份、栀子20份、地肤子20份。
6.一种根据权利要求1~5任意一项所述的中药组合物在制备治疗外阴炎、阴道炎、宫颈炎、宫颈糜烂、盆腔炎的药物中的应用。
7.一种治疗妇科疾病的中药制剂,其特征在于,包括权利要求1~5任一项所述的中药组合物和药学上可接受的辅料。
8.根据权利要求7所述的治疗妇科疾病的中药制剂,其特征在于,所述制剂的剂型包括凝胶、喷剂、洗液、乳膏或乳霜。
9.一种根据权利要求8所述的治疗妇科疾病的中药制剂的制备方法,其特征在于,包括如下步骤:
S1:按照比例称取各原料,将原料干燥、粉碎成细粉,过筛,并灭菌;
S2:将上述原料细粉加入到水中,煎煮4h后,滤去沉淀,取煎液,将上清液过滤、浓缩至清膏;
S3:将丙二醇、薄荷脑、冰片、甘油、维他命E1、醋酸氯己定和苯海拉明混合搅拌均匀,加入清膏中,混合搅拌均匀,获得药效溶液;
S4:将得到的药效溶液配合不同的辅料,即可制成不同剂型的制剂。
10.根据权利要求9所述的治疗妇科疾病的中药制剂的制备方法,其特征在于,当制备成凝胶制剂时:S4中将药效溶液中加入基于卡波姆940的凝胶基质,混合搅拌均匀,将凝胶灌装至给药器内,密封,即得凝胶制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110653040.6A CN113181336A (zh) | 2021-06-11 | 2021-06-11 | 一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110653040.6A CN113181336A (zh) | 2021-06-11 | 2021-06-11 | 一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113181336A true CN113181336A (zh) | 2021-07-30 |
Family
ID=76976566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110653040.6A Pending CN113181336A (zh) | 2021-06-11 | 2021-06-11 | 一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113181336A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116459312A (zh) * | 2022-01-12 | 2023-07-21 | 北京世道守正中医药研究院 | 用于防治妇科疾病的中药组合物、水提取物、制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535481A (zh) * | 2015-12-31 | 2016-05-04 | 蒲敬北 | 一种阴道外用复方中药凝胶及其制作方法 |
CN105998972A (zh) * | 2016-06-15 | 2016-10-12 | 许照东 | 一种抑菌凝胶剂 |
CN108452151A (zh) * | 2018-03-15 | 2018-08-28 | 广州佳静健康产业有限公司 | 一种阴道护理凝胶 |
CN108553567A (zh) * | 2018-06-04 | 2018-09-21 | 吉林敖东集团大连药业股份有限公司 | 一种妇科洗液及其制备方法 |
-
2021
- 2021-06-11 CN CN202110653040.6A patent/CN113181336A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535481A (zh) * | 2015-12-31 | 2016-05-04 | 蒲敬北 | 一种阴道外用复方中药凝胶及其制作方法 |
CN105998972A (zh) * | 2016-06-15 | 2016-10-12 | 许照东 | 一种抑菌凝胶剂 |
CN108452151A (zh) * | 2018-03-15 | 2018-08-28 | 广州佳静健康产业有限公司 | 一种阴道护理凝胶 |
CN108553567A (zh) * | 2018-06-04 | 2018-09-21 | 吉林敖东集团大连药业股份有限公司 | 一种妇科洗液及其制备方法 |
Non-Patent Citations (2)
Title |
---|
张晓春等: "复发性念珠菌性外阴阴道炎中医药治疗思路", 《四川中医》 * |
梁月冬: "治疗阴道炎几种外用制剂的比较分析", 《首都医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116459312A (zh) * | 2022-01-12 | 2023-07-21 | 北京世道守正中医药研究院 | 用于防治妇科疾病的中药组合物、水提取物、制剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105833279B (zh) | 皮肤多种损伤创面治疗的外用药物组合物及其制备方法 | |
CN102145111B (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN101537107A (zh) | 有效治疗皮肤真菌病的外用擦剂及其制备方法 | |
CN113081928A (zh) | 一种植物抑菌凝胶及其制备方法和应用 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
CN102836228B (zh) | 一种治疗结膜炎的中药组合物及其制备方法和应用 | |
CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
CN105560372A (zh) | 一种治疗鼻炎的中药喷雾剂及其制备方法 | |
CN104940727A (zh) | 一种治疗鼻炎的膏剂及其制备方法 | |
CN102743662B (zh) | 治疗妇科炎症的壮药制剂及其制备方法 | |
CN103181958A (zh) | 治疗奶牛子宫内膜炎的中草药灌注液及其制备方法 | |
CN113181336A (zh) | 一种治疗妇科疾病的中药组合物、制剂及其制备方法和应用 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN101391065A (zh) | 一种用于治疗急慢性盆腔炎的复方木鳖子花椒汤 | |
CN103599437B (zh) | 一种治疗阴道炎的中药药液 | |
CN103721138A (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN110384785B (zh) | 一种用于治疗病毒性感冒的外用中药药液及其制备方法 | |
CN106728069B (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
CN107536937B (zh) | 一种治疗皮肤病和灰指甲的外用中药药液及其制备方法 | |
CN112618626A (zh) | 一种治疗带状疱疹的中药喷雾剂及其制备方法 | |
CN100551420C (zh) | 一种具有抗生素功效的中药外用乳浊液制剂及其制备方法 | |
CN115400172B (zh) | 一种治疗蚊虫叮咬的中药组合物及其制备方法 | |
CN113633717B (zh) | 鼻腔护理电子雾化液组合物、其用途及所得的护理产品 | |
CN117045717B (zh) | 一种治疗湿疹的外用复方精油组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |